About | HeinOnline Law Journal Library | HeinOnline Law Journal Library | HeinOnline
LOG IN
LOG IN

1 H.R. 938, Bringing Low-Cost Options and Competition While Keeping Incentives for New Generics Act of 2019 1 (2019)

handle is hein.congrec/bglwop0001 and id is 1 raw text is: j Congressional Budget Office Cost Estimate April 26, 2019 Millions of Dollars 2019 20192024 2019o2029 Direct Spending (Outlays) 0 -124 -374 Revenues 0 0 Deficit Effect 23 -147 68 -442 Under current law, manufacturers of generic drugs may seek approval from the Food and Drug Administration (FDA) to market a generic drug before the expiration of a patent listed with the FDA for the brand-name product. The first generic applicant that submits a substantially complete application to the FDA challenging an innovator's patent claim may be awarded 180 days of generic market exclusivity. (The FDA cannot approve any other generic versions of the drug during that 180-day period.) If certain conditions are met, the exclusivity period begins upon the first applicant's commercial marketing. H.R. 938 would allow the FDA to approve a subsequent generic drug application that is ready for full approval if no first applicant has received final approval and other conditions are satisfied. In such cases, the exclusivity period would be triggered and would run for 180 days after which time the subsequent applicant could enter the market. CBO expects that the bill's provisions would allow generic drugs to enter the market earlier, on average, than they would under current law. Because of the earlier entry of lower-priced generic drugs, CBO estimates, enacting the legislation would reduce federal spending on prescription drugs and subsidies for health insurance. In total, CBO estimates that enacting H.R. 938 would decrease the deficit by $442 million over the 2019-2029 period. That amount includes a $374 million reduction in direct spending and a $68 million increase in revenues. See also CBO's Cost Estimates Explained, www cbo.gov/pubicationi54437; How CBO Prepares Cost Estimates, www.cbo.gov/pubication!53519; and Glossary, www.cbo~govipublication/42904.

What Is HeinOnline?

HeinOnline is a subscription-based resource containing thousands of academic and legal journals from inception; complete coverage of government documents such as U.S. Statutes at Large, U.S. Code, Federal Register, Code of Federal Regulations, U.S. Reports, and much more. Documents are image-based, fully searchable PDFs with the authority of print combined with the accessibility of a user-friendly and powerful database. For more information, request a quote or trial for your organization below.



Short-term subscription options include 24 hours, 48 hours, or 1 week to HeinOnline.

Purchase Access

Contact us for annual subscription options:

Contact Us

Already a HeinOnline Subscriber?

Log In

profiles profiles most